List of all news

28. 8. 2015
...continue

Registration of Temozolomide in Russia

The company IMCoPharma offers the exclusive product Temozolomide - the pharmaceutical substance for use in oncological medicine with quality according to USP, produced by company

...continue

20. 8. 2015
...continue

Authorization to handle with narcotic drugs and psychotropic substances

The company IMCoPharma was authorized by Ministry of Health of the Czech Republic to handle with narcotic drugs and psychotropic substances, pursuant to section 4 of Act.

...continue

14. 8. 2015
...continue

Adenosine (CMO)

The company IMCoPharma offers to its clients exclusive final product based on Adenosine - endogenous nucleoside with peripheral vasodilator/antiarrhythmic effect, manufactured by

...continue

13. 8. 2015
...continue

Paracetamol + Vitamin C + Pheniramine (CMO)

The company IMCoPharma offers to its clients exclusive final product based on Paracetamol + Vitamin C + Pheniramine (Generic of Fervex), manufactured by company FAREVA

...continue

7. 8. 2015
...continue

Moxifloxacin Hydrochloride Injection and Oral Grade

The company IMCoPharma offers the exclusive product Moxifloxacin Hydrochloride - the pharmaceutical substance used as antibiotic with quality according to EP and USP, produced by

...continue

6. 8. 2015
...continue

Contract manufacturing and development services

The company IMCoPharma has initiated cooperation with company Fareva (France), which owns many manufacturing plants with various technological capabilities and offers contract

...continue

5. 8. 2015
...continue

Registration of Methotrexate disodium salt in Ukraine and Russia

The company IMCoPharma has recently completed registration of Methotrexate disodium salt in Ukraine, pharmaceutical substance for use in oncological medicines, produced by Excella

...continue

31. 7. 2015
...continue

imcobuy at CPhI Russia 2015

On 27 – 29 April 2015, the company IMCoPharma succesfully participated for the third time with own stand at pharmaceutical exhibition CPhI Russia 2015 (Moscow) and introduced its

...continue

27. 7. 2015
...continue

Export of narcotic drugs and psychotropic substances

The company IMCoPharma constantly expanding its activities within CIS countries. In order to fullfill requirements of our customers, we are in the process of obtaining export

...continue

24. 7. 2015
...continue

Technology transfer of Gadopentetate (MRT contrast agent)

After successful implementation of project Iohexol (contrast agent in clinical imaging), IMCoPharma has expanded portfolio by another product of company iMAX Diagnostic Imaging

...continue

23. 7. 2015
...continue

Pharmaceutical Salt for Hemodialysis solutions

IMCoPharma would like to promote new product of company Salinen Austria - Pharmasal HD (Pharmaceutical Salt for Hemodialysis solutions), available from 1st of August 2015. For

...continue

23. 7. 2015
...continue

Cooperation IMCoPharma and F.I.S. (Italy)

IMCoPharma is starting a cooperation with Italian pharma company F.I.S. - Fabbrica Italiana Sintetici, the largest API´s producer in Italy (http://fischemicals.com/?lang=en). By

...continue

Use an opportunity to meet us:

Madrid, Spain<br />
13th – 15th October 2015<br />
stand no.: 3J11

Madrid, Spain
13th – 15th October 2015
stand no.: 3J11

Moscow, Russia<br />
24th - 27th November 2015<br />
Stand no.: A113/hall 7

Moscow, Russia
24th - 27th November 2015
Stand no.: A113/hall 7

Moscow, Russia<br />
30th March - 1st April 2016

Moscow, Russia
30th March - 1st April 2016

version dated 2.9.2015, time 10:30